ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Vyriad to Develop Antibody Test to Determine COVID-19 Protective Immunity
May 18, 2020Vyriad has completed the development of a serology test to measure protective immunity against SARS-CoV-2, the novel coronavirus that causes COVID-19. -
Vyriad Announces Collaboration with Merck KGaA and Pfizer to Evaluate Voyager-V1, Avelumab
July 24, 2018Vyriad has announced a collaboration agreement with Merck KGaA, Darmstadt, Germany, and Pfizer to expand its ongoing Phase 1 clinical trial program in solid tumors to include a combination study of its lead asset, Voyager-V1, with avelumab, a human anti-P -
Vyriad signs a contract with IBM to build an oncolytic virus anti-cancer vaccines manufacturing facility
May 14, 2018The custom buildout will be financed with proceeds from a recently completed $9 million secured convertible note financing...
Pharma Sources Insight January 2025
